Alagille syndrome


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Alagille syndrome (AS) is a rare multisystem autosomal dominant hereditary disease. It may be identified on the basis of a number of clinical signs: cholestasis, heart disease, skeletal abnormalities, typical facial appearance, and eyeball abnormalities. AS is accompanied by growth retardation and delayed physical development. Obvious hypoplasia of the intrahepatic bile ducts is noted; defects of the liver can cause its end-stage disease that needs transplantation. Most of fatal AS cases are due to cardiovascular diseases: injury of the pulmonary artery, its branches (more commonly stenosis) and valve; directly that of the heart (tetralogy of Fallot, ventricular and atrial septal defects, aortic stenosis and coarctation); cerebrovascular diseases (cerebral aneurysms, arteriopathy, dolichoectasia, moya-moya disease). Bone abnormalities are common in AS; these are butterfly vertebrae, vertebral fusion, hemivertebrae, intercostal joints, shortened fingers, a convex forehead, moderate hypertelorism with deep-set eyes, a saddle-shaped or straight nose with a flattened-convex tip and large ears. AS is also manifested by severe growth retardation, chronic exhaustion, and sometimes moderate mental retardation. Specific therapy for AS has not been developed. The paper describes clinical cases (an 11-year-old boy and his 5-year-old sister). The children complained of obvious itching, dry and tightened skin; AS was manifested by a complete set of the above clinical signs with delayed mental and physical development. Only a few years later, the specialists from regional and federal clinics of Russia diagnosed AS on the basis of a set of symptoms. The authors note that both patients have a number of clinical manifestations that may be signs of AS, such as talipes valgus; funnel-shaped deformation of the chest; ichthyosi form lesions of the axillary regions; watch-glass nails; thinning and brittle hair.

Full Text

Restricted Access

About the authors

M. N Gadzhimuradov

Dagestan State Medical University

Email: gabenu@mail.ru
MD Makhachkala

M. G Alieva

Dagestan State Medical University

Email: gabenu@mail.ru
Makhachkala

G. D Mamasheva

Dagestan State Medical University

Email: gabenu@mail.ru
Candidate of Medical Sciences Makhachkala

References

  1. Назаренко Л.П. Федеральные клинические рекомендации по диагностике и лечению синдрома Алажиля. М., 2015; 25
  2. Krantz I., Piccoli D., Spinner N. Alagille syndrome. J Med Genet. 1997; 34 (2): 152-7. doi: 10.1136/jmg.34.2.152
  3. Омельченко Е.В., Ермолаев М.Н., Сенаторова А.С. Артериопеченочная дисплазия (Синдром Алажиля) у ребенка (клиническое наблюдение). Здоровя дитини. Тематический выпуск «Дитяма гастроентерологія». 2015; 62: 128-32
  4. Дягтерева А.В., Болмасова А.В., Филиппова Е.А. и др. Физическое развитие ребенка с синдромом Алажиля до и после трансплантации печени. Вопросы практической педиатрии. 2018; 13 (2): 64-9 doi: 10.20953/1817-7646-2018-2-64-69
  5. Горячова Л.П., Шилова И.В., Рогозина Н.В. и др. Синдром Алажиля в клинической практике. Журнал инфектологии. 2013; 5 (4): 72-6
  6. Benabed Y., Chaillou E., Denis M. et al. Alagille syndrome: a case report. Ann Biol Clin (Paris). 2018; 76 (6): 675-80. doi: 10.1684/abc.2018.1399
  7. Mitchell E., Gilbert M., Loomes K. Alagille Syndrome. Clin Liver Dis. 2018; 22 (4): 625-41. doi: 10.1016/j.cld.2018.06.001
  8. Carpenter C., Linscott L., Leach J. et al. Spectrum of cerebral arterial and venous abnormalities in Alagille syndrome. Pediatr Radiol. 2018; 48 (4): 602-8. doi: 10.1007/s00247-017-4043-2
  9. Ho D., Levin A., Anninger W. et al. Anterior Chamber Pathology in Alagille Syndrome. Ocul Oncol Pathol. 2016; 2 (4): 270-5. doi: 10.1159/000446804
  10. Kim J., Yang B., Paik N. et al. A case of Alagille syndrome presenting with chronic cholestasis in an adult. Clin Mol Hepatol. 2017; 23 (3): 260-4. doi: 10.3350/cmh.2016.0057
  11. Di Pinto D., Adragna M. Renal manifestations in children with Alagille syndrome. Arch Argent Pediatr. 2018; 116 (2): 149-53. doi: 10.5546/aap.2018. eng.149
  12. Berniczei-Royko A., Chalas R., Mitura I. et al. Medical and dental management of Alagille syndrome: a review. Med Sci Monit. 2014; 20: 476-80. doi: 10.12659/MSM.890577

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies